Background: Vancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISA isolates are usually reported as vancomycin susceptible by routine susceptibility testing procedures.
View Article and Find Full Text PDFWe report a case of soft tissue infection, sepsis, and bacteremia due to (melioidosis) in a diabetic young patient and the genomic characterization of isolate (COL-5428).
View Article and Find Full Text PDF